Techbio platform leveraging the smartest collection of tumour avatars to transform oncology drug development
Orakl Oncology has raised €14M across 2 funding rounds from 7 investors, most recently a Seed round in Dec 2024. Based in Villejuif, France; active in Healthtech. Data as of 7 Aug 2026.
Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2024-12-03 | Seed | €11M | Bpifrance,Existing investors,Grand Prix i-Lab,Singular | View deal → |
| 2023-10-05 | Other | €3.0M | HCVC,Speedinvest,Verve Ventures | View deal → |
